Logo for GNW.jpg
Avisa Diagnostics Reports on Status of Interim Filings
November 24, 2021 07:00 ET | Avisa Diagnostics Inc.
SANTA FE, N.M. and MALVERN, Pa., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT) (“Avisa” or the “Company”), a clinical-stage medical device company developing an ultra-rapid,...
Logo for GNW.jpg
Avisa Diagnostics Appoints Dr. Richard Murray as Chief Medical Officer
September 01, 2021 07:00 ET | Avisa Diagnostics Inc.
SANTA FE, N.M. and MALVERN, Pa., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT) (Avisa), a clinical-stage medical device company developing an ultra-rapid, point-of-care...
Logo for GNW.jpg
Avisa Diagnostics Announces Closing of Non-Brokered Private Placement of Common Shares
August 25, 2021 16:10 ET | Avisa Diagnostics Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. SANTA FE, N.M. and MALVERN, Pa., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT)...
Logo for GNW.jpg
Avisa Diagnostics Announces Non-Brokered Private Placement of Common Shares
August 20, 2021 15:50 ET | Avisa Diagnostics Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. SANTA FE, N.M. and MALVERN, Pa., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT)...
Logo for GNW.jpg
Avisa Diagnostics Announces Closing of Non-Brokered Private Placement of Common Shares
July 19, 2021 16:05 ET | Avisa Diagnostics Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. SANTA FE, N.M. and MALVERN, Pa., July 19, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT)...
Logo for GNW.jpg
Avisa Diagnostics Announces Non-Brokered Private Placement of Common Shares
July 12, 2021 15:50 ET | Avisa Diagnostics Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. SANTA FE, N.M. and MALVERN, Pa., July 12, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT)...
Logo for GNW.jpg
Avisa Diagnostics to Participate at Upcoming Investor Events
July 09, 2021 07:00 ET | Avisa Diagnostics Inc.
SANTA FE, N.M. and MALVERN, Pa., July 09, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT) (Avisa), a clinical-stage medical device company developing an ultra-rapid, point-of-care...
20210310_AVISA_logo for PR.JPG
Avisa Diagnostics Appoints G. Michael Landis as Chief Financial Officer
June 22, 2021 07:00 ET | Avisa Diagnostics Inc.
Financial executive with strong public company experience joins growing Avisa team SANTA FE, N.M., June 22, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT) (Avisa), a clinical-stage...
20210310_AVISA_logo for PR.JPG
Avisa Diagnostics to Participate in Renmark’s Virtual Non-Deal Roadshow Series on June 17, 2021
June 17, 2021 07:00 ET | Avisa Diagnostics Inc.
SANTA FE, N.M., June 17, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE: AVBT) (Avisa), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test...
20210310_AVISA_logo for PR.JPG
Avisa Diagnostics Appoints Barbara Bunger, PhD as Vice President, Clinical Development
June 02, 2021 07:00 ET | Avisa Diagnostics Inc.
SANTA FE, N.M., June 02, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT) (Avisa), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test...